Financials data is unavailable for this security.
View more
Year on year AstraZeneca PLC grew revenues 3.29% from 44.35bn to 45.81bn while net income improved 81.11% from 3.29bn to 5.96bn.
Gross margin | 82.21% |
---|---|
Net profit margin | 13.12% |
Operating margin | 18.42% |
Return on assets | 6.42% |
---|---|
Return on equity | 16.75% |
Return on investment | 8.84% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at AstraZeneca PLC fell by 346.00m. However, the company earned 10.35bn from its operations for a Cash Flow Margin of 22.58%. In addition the company used 4.06bn on investing activities and also paid 6.57bn in financing cash flows.
Cash flow per share | 5.73 |
---|---|
Price/Cash flow per share | 17.24 |
Book value per share | 19.73 |
---|---|
Tangible book value per share | -10.47 |
More ▼
Balance sheet in USDView more
Current ratio | 0.8889 |
---|---|
Quick ratio | 0.6905 |
Total debt/total equity | 0.8487 |
---|---|
Total debt/total capital | 0.4585 |
More ▼
Growth rates in USD
SmartText is unavailable
Div yield(5 year avg) | 2.44% |
---|---|
Div growth rate (5 year) | 1.10% |
Payout ratio (TTM) | 0.00% |
EPS growth(5 years) | 17.52 |
---|---|
EPS (TTM) vs TTM 1 year ago | 4.41 |
More ▼